Stay updated on IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error screen, replacing the study information with a standard access-denied layout. This makes the record temporarily inaccessible to users.
    Difference
    19%
    Check dated 2026-09-20T22:37:43.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The NIH grant/contract note was added to the study identifiers, and the page revision tag was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:23:15.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The study page now shows an error message and a minimal HTML structure, indicating the record is currently unavailable.
    Difference
    18%
    Check dated 2026-08-09T11:19:28.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new site release is in effect, without altering any study content or data on the page.
    Difference
    0.0%
    Check dated 2026-07-26T00:15:45.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, signaling a new version of the page content.
    Difference
    0.0%
    Check dated 2026-07-04T13:26:21.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This represents a new build of the page without altering the study data or content.
    Difference
    0.0%
    Check dated 2026-06-27T06:29:44.000Z thumbnail image

Stay in the know with updates to IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.